Melanotan 2 Reconstitution: The Dose Follows Weight

How much water a 5 or 10 mg Melanotan II vial takes, and why a per-kilogram published dose makes the syringe reading depend on the person, not the vial.

Medibact Guides · Published 2026-09-21

Illustration: Two clear glass vials, one with lyophilized powder, one with water, an insulin syringe.
Illustration

Every reconstitution page on this site answers the same three questions: how much water, what concentration, how many units. Melanotan II is the compound where the third question has no single answer, because the only published human doses for it are stated per kilogram of body weight. The same vial, at the same concentration, reads as thirty units for one person and fifty for another. This page works the arithmetic through with weight as an explicit column, reports what the published figures are and where they came from, and records what the registry does and does not contain. It reports and does not recommend.

The Melanotan II calculator runs the same sums for any vial and volume, the sourced dose figures and their provenance are on the Melanotan II dosage page, and every compound's arithmetic is indexed on the reconstitution hub.

Water per vial and the concentration it gives

One U-100 unit is a hundredth of a millilitre.

Vial Water Concentration One unit holds
5 mg 1 mL 5,000 mcg/mL 50 mcg
5 mg 2 mL 2,500 mcg/mL 25 mcg
5 mg 3 mL 1,667 mcg/mL 16.7 mcg
10 mg 1 mL 10,000 mcg/mL 100 mcg
10 mg 2 mL 5,000 mcg/mL 50 mcg
10 mg 3 mL 3,333 mcg/mL 33.3 mcg

Nothing on this page is unusual so far; this is the ordinary table. What follows is where this compound differs from the rest of the set.

Bacteriostatic Water, 30 mL vial

Bacteriostatic Water

USP-grade, 0.9% benzyl alcohol, 30 mL multi-dose vial. Research use only.

$30.99

Buy at Medibact

The column a calculator cannot fill in

The published human figure is 0.025 mg/kg. Converting it into micrograms requires a body weight, and converting that into syringe units requires the concentration as well. Both tables below use the 0.025 mg/kg figure from the two Wessells studies.

From a 10 mg vial:

Body weight Amount at 0.025 mg/kg In 1 mL (10,000 mcg/mL) In 2 mL (5,000 mcg/mL) In 3 mL (3,333 mcg/mL)
60 kg 1,500 mcg 15 units 30 units 45 units
70 kg 1,750 mcg 17.5 units 35 units 52.5 units
80 kg 2,000 mcg 20 units 40 units 60 units
90 kg 2,250 mcg 22.5 units 45 units 67.5 units
100 kg 2,500 mcg 25 units 50 units 75 units

From a 5 mg vial:

Body weight Amount In 1 mL (5,000 mcg/mL) In 2 mL (2,500 mcg/mL) In 3 mL (1,667 mcg/mL)
60 kg 1,500 mcg 30 units 60 units 90 units
70 kg 1,750 mcg 35 units 70 units 105 units — more than one syringe
80 kg 2,000 mcg 40 units 80 units more than one syringe
90 kg 2,250 mcg 45 units 90 units more than one syringe
100 kg 2,500 mcg 50 units 100 units — a full syringe more than one syringe

The bottom right of the second table is the constraint most likely to be met in practice: a 5 mg vial in 3 mL is dilute enough that the published per-kilogram amount no longer fits in a single U-100 syringe. That is not an argument about what anyone should do; it is the point at which the arithmetic stops working and has to be redone at a different volume.

How the published figures compare with the circulating ones

Source Figure For a 70 kg adult In units from 10 mg in 2 mL
Dorr 1996, phase 1 starting dose (PMID 8637402) 0.01 mg/kg 700 mcg 14 units
Dorr 1996, escalated (PMID 8637402) 0.025 to 0.03 mg/kg 1,750 to 2,100 mcg 35 to 42 units
Wessells 1998 and 2000 (PMID 9679884, 11018622) 0.025 mg/kg 1,750 mcg 35 units
Vendor pages, per this site's chart (2026-09-18) 100 to 1,000 mcg, fixed 100 to 1,000 mcg 2 to 20 units

The published human amounts sit above the circulating ones, which is the reverse of the pattern on most pages here. It is worth being precise about what that does and does not mean. The trial figures come from single doses and short courses given under direct observation — the phase 1 study ran weekdays for two consecutive weeks in three volunteers, and escalated one subject to 0.03 mg/kg where Grade II somnolence and fatigue appeared in one of two subjects at that level. They are not figures for repeated unsupervised use, and the studies did not test that. The vendor figures, for their part, have no study behind them that this site could locate.

How many amounts a vial holds

Set by the milligrams alone, unchanged by the water:

Amount 5 mg vial 10 mg vial
1,750 mcg (0.025 mg/kg at 70 kg) 2, with 1.5 mg left 5, with 1.25 mg left
1,000 mcg 5 10
500 mcg 10 20
250 mcg 20 40

What is not established

Melanotan II is not approved anywhere this site could verify. DailyMed returned no record for "melanotan" on 2026-09-21, checked alongside searches that did return results.

The registry position is more interesting than a count suggests. ClinicalTrials.gov holds exactly one Melanotan II registration, NCT07437560 — a phase 2 vitiligo study of 60 participants at Peking University Shenzhen Hospital, sponsored by Hudson Biotech, first posted on 27 February 2026 and recorded as recruiting. Its brief summary opens: "This example interventional study record describes a randomized Phase 2 clinical trial…". The record describes itself as an example. Its status field says recruiting, its phase field says 2 and its enrolment field says 60, and none of those fields carries any hint of the sentence that undoes them. Anyone counting registered trials for this molecule from the structured fields would report one; reading the summary gives zero.

The approved relative is worth knowing about for a different reason. Afamelanotide, sold as SCENESSE, is a subcutaneous implant — a solid rod placed under the skin, not a powder and not a solution. It has a current DailyMed label published on 13 May 2026 and 23 registered studies. The chemical family therefore does contain an approved product, and that product has no reconstitution arithmetic at all, because nothing about it is ever mixed with water.

The mechanism and the evidence file are covered in Medibact's Melanotan II guide. For the compound whose amounts run in the opposite direction — milligram doses a single vial barely covers — see the ARA-290 dosage page. For the general case of converting a published figure into what a syringe reads, the insulin syringe units guide sets out the arithmetic once.

Bacteriostatic Water, 30 mL vial

Bacteriostatic Water

USP-grade, 0.9% benzyl alcohol, 30 mL multi-dose vial. Research use only.

$30.99

Buy at Medibact

Frequently asked questions

How much bacteriostatic water goes into a 10 mg Melanotan II vial?

No label sets it, because no Melanotan II vial has one. The calculator's presets are 1, 2 and 3 mL, giving 10,000, 5,000 and 3,333 mcg/mL from a 10 mg vial and 5,000, 2,500 and 1,667 mcg/mL from a 5 mg vial. The milligrams in the vial are the same at every volume; the water decides only how large the reading is. Because this compound's published amounts are per kilogram, the volume that makes a reading convenient depends on the body weight the amount is calculated from.

How many units is 0.025 mg/kg of Melanotan II?

It depends on the person as well as the vial. At 0.025 mg/kg the amount is 1,500 mcg at 60 kg, 1,750 at 70 kg, 2,000 at 80 kg, 2,250 at 90 kg and 2,500 at 100 kg. From a 10 mg vial in 2 mL — 5,000 mcg/mL — those read as 30, 35, 40, 45 and 50 units. From the same vial in 1 mL they read as 15, 17.5, 20, 22.5 and 25 units. This is the practical difference between a per-kilogram figure and a fixed one: the same concentration gives a different reading for two different people.

How many doses does a Melanotan II vial hold?

At the 0.025 mg/kg published figure for a 70 kg adult — 1,750 mcg — a 10 mg vial holds five such amounts with 1.25 mg left over, and a 5 mg vial holds two with 1.5 mg left. At the smaller vendor figures the same vials go much further: at 500 mcg a 10 mg vial is 20 draws and a 5 mg vial is 10. The count comes from the milligrams alone and never changes with the water.

Why does the trial dose depend on body weight when the vendor figures do not?

Because the trials were designed as pharmacology studies and dosed the way such studies normally dose a systemically acting peptide — proportionally to the person. The fixed microgram figures that circulate for the vial have no published study behind them that this site could find; they are recorded on its chart as vendor figures rather than as trial protocol. The gap is worth seeing rather than averaging: a per-kilogram figure and a fixed figure are two different kinds of claim, and only one of them came from a study.

Is there a registered Melanotan II trial?

One registration exists and it describes itself as an example record. NCT07437560 lists a phase 2 vitiligo study of 60 participants at a single hospital, recorded as recruiting, and its brief summary begins 'This example interventional study record describes'. Nothing in the status, phase or enrolment fields shows this — only the summary text does. Read that way, the compound has no genuine registered trial, and a count of registrations taken from the fields alone would report one where the answer is zero.

Is Melanotan II the same as the approved product Scenesse?

No, and the difference is instructive for a reconstitution page. SCENESSE is afamelanotide, a different alpha-MSH analogue, and it is supplied as a subcutaneous implant rather than a powder — a solid dosage form placed under the skin that is never mixed with water at all. Its label was published on DailyMed on 13 May 2026 and it has 23 registered studies. So the approved member of this chemical family is not a vial, has no reconstitution arithmetic, and is not what a Melanotan II vial contains.